Maxwell Wealth Strategies Inc. Has $2.74 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Maxwell Wealth Strategies Inc. lifted its position in IQVIA Holdings Inc. (NYSE:IQV) by 37.3% in the third quarter, HoldingsChannel.com reports. The firm owned 11,570 shares of the medical research company’s stock after acquiring an additional 3,145 shares during the period. IQVIA comprises 1.2% of Maxwell Wealth Strategies Inc.’s investment portfolio, making the stock its 26th largest holding. Maxwell Wealth Strategies Inc.’s holdings in IQVIA were worth $2,742,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. First Foundation Advisors increased its stake in IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after acquiring an additional 43 shares during the period. Invera Wealth Advisors LLC boosted its position in IQVIA by 0.3% in the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock valued at $3,183,000 after buying an additional 46 shares in the last quarter. Covestor Ltd grew its position in IQVIA by 45.3% during the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock worth $39,000 after acquiring an additional 48 shares during the last quarter. Oregon Public Employees Retirement Fund grew its holdings in shares of IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after purchasing an additional 48 shares during the last quarter. Finally, Continuum Advisory LLC increased its position in IQVIA by 3.3% in the 2nd quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock valued at $325,000 after acquiring an additional 49 shares in the last quarter. 89.62% of the stock is owned by institutional investors.

IQVIA Stock Down 5.1 %

NYSE IQV opened at $192.68 on Friday. The company has a 50 day moving average of $226.95 and a 200-day moving average of $228.29. The company has a market cap of $34.97 billion, a price-to-earnings ratio of 25.28, a PEG ratio of 2.17 and a beta of 1.51. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA Holdings Inc. has a 1-year low of $189.63 and a 1-year high of $261.73.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on IQV shares. Argus upgraded IQVIA to a “strong-buy” rating in a research report on Wednesday, July 31st. Evercore ISI cut their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. TD Cowen decreased their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $270.00 target price on shares of IQVIA in a report on Friday, November 1st. Finally, Robert W. Baird decreased their price target on shares of IQVIA from $256.00 to $223.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $259.13.

Insider Transactions at IQVIA

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 6.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by insiders.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.